Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Dow
McKinsey
Harvard Business School
AstraZeneca
Moodys
Fuji
Accenture
Express Scripts

Generated: October 20, 2018

DrugPatentWatch Database Preview

Rubicon Res Pvt Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for RUBICON RES PVT LTD, and what generic and branded alternatives to RUBICON RES PVT LTD drugs are available?

RUBICON RES PVT LTD has five approved drugs.

There is one tentative approval on RUBICON RES PVT LTD drugs.

Summary for Rubicon Res Pvt Ltd
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Rubicon Res Pvt Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon Res Pvt Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 204882-002 Jun 11, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Rubicon Res Pvt Ltd METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 200981-001 Oct 28, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Rubicon Res Pvt Ltd SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 204883-001 Jun 20, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Rubicon Res Pvt Ltd BACLOFEN baclofen TABLET;ORAL 209102-001 Nov 28, 2017 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Citi
Covington
Queensland Health
Harvard Business School
QuintilesIMS
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.